The presence of Th1 CD4+ T-cells and cytotoxic CD8+ T-cells in the tumor microenvironment has been associated with an improved prognosis, while FOXP3+ regulatory T-cells are associated with the downregulation of the immune response and a poorer prognosis [80,86]. The gene discussed is FOXP3; the disease is neoplasm.